Liberty Bankers Life Ins Co (illumifin) Files Indiana Data Event Notice
Liberty Bankers Life Ins Co (illumifin) reported a data event impacting personal information, with a breach date of October 28, 2025. The company filed notice of the incident with Indiana officials on April 10, 2026, and an investigation into the matter is ongoing. Affected individuals are encouraged to review any direct notifications they receive.
- State
- IN
- Breach date
- October 28, 2025
- Reported
- April 10, 2026
Liberty Bankers Life Ins Co (illumifin) recently filed a data event notice with officials in Indiana concerning an incident that potentially exposed personal information. The company submitted its filing on April 10, 2026, acknowledging a breach event that occurred several months prior.
The reported breach date for this incident is October 28, 2025. At present, Liberty Bankers Life Ins Co (illumifin) has indicated that an investigation into the event is still underway. The official public filing does not specify the exact types of personal information that may have been involved in this breach.
Furthermore, the total number of individuals whose data may have been affected by this incident has not been specified in the public record. Those who receive direct notification from Liberty Bankers Life Ins Co (illumifin) should carefully review the information provided to understand the specifics of their situation.
Individuals who believe they may be affected by this data event are advised to remain vigilant. It is recommended to monitor your financial accounts and credit reports for any signs of unusual or unauthorized activity. Additionally, be cautious of any unsolicited communications that request personal details, as these could be attempts at phishing or identity theft.
This information is based on public filings made with state regulators. For precise details regarding the data event and any recommended protective measures, individuals should refer to any official notices received directly from Liberty Bankers Life Ins Co (illumifin).
Source: Attorney General filing